Iovance Biotherapeutics, Inc. (IOVA)

3.86 +0.06 (+1.58%) USD  |  NASDAQ  |  Apr 17, 16:00
3.75 -0.11 (-2.85%) After-Hours: 06:40
More

Iovance Biotherapeutics SG&A Expense (Quarterly) : 36.40M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for IOVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Orthofix Medical, Inc. 136.75M
InfuSystem Holdings, Inc. 16.51M
Axogen, Inc. 41.80M
Avanos Medical, Inc. 78.80M
KalVista Pharmaceuticals, Inc. 61.00M